(Reuters) – Moderna Inc. said on Tuesday it had received a report from the California Department of Health that several people in a San Diego center had been treated for possible allergic reactions to the COVID-19 vaccine in a particular group.
The company’s comments come after the top California epidemiologist issued a statement on Sunday recommending suppliers to stop vaccination in lot no. 41L20A due to possible allergic reactions that are under investigation.
“More than usual number of possible allergic reactions have been reported with a certain batch of Moderna vaccine given at a community vaccination clinic. Less than 10 people needed medical care over a 24-hour period,” he said. the epidemiologist in a statement here.
The vaccine manufacturer said it was not aware of comparable cases of adverse events in other vaccination centers that could have administered vaccines in the same batch or in other batches of its vaccine.
A total of 307,300 doses in the batch remain stored, Moderna said, out of a total of 1,272,200 doses that were produced in the batch.
Moderna said it is working closely with US health regulators to understand the cases and whether it is justified to discontinue use of the batch.
Nearly one million doses in the batch have already been distributed to about 1,700 vaccination sites in 37 states, Moderna said. (bit.ly/39MPtlF)
Report by Manojna Maddipatla in Bengaluru; Editing by Vinay Dwivedi and Shinjini Ganguli